Pharmacotherapy Adherence for Pediatric Anxiety Disorders: Predictors and Relation to Child Outcomes
Pharmacotherapy is considered an evidenced-based treatment for anxious youth. There is a need to better understand the relation between medication adherence and child outcomes.
This study prospectively examined: (1) baseline predictors of adherence and (2) the relation between medication adherence and clinical outcomes in children and adolescents with anxiety disorders.
Participants were 349 youth randomized to sertraline, pill placebo, or sertraline plus cognitive behavioral therapy in the Child/Adolescent Anxiety Multimodal Study and followed over 12 weeks. The measure of pharmacotherapy adherence used was pharmacotherapist (PT) ratings of adherence at each session. Four domains of baseline predictors were examined (demographics, child clinical variables, family/parent variables, and treatment variables).
Multiple regression analyses revealed few significant predictors of adherence. The most robust predictors of greater adherence were living with two parents and parents’ positive expectations that medication would lead to better outcomes. PTs ratings of higher adherence predicted higher global functioning at post treatment and treatment responder status.
In order to increase adherence, improving expectations and instilling hope for positive outcomes and problem solving ways to overcome pragmatic barriers associated with single parent families is recommended.
KeywordsAnxiety Adherence Selective serotonin reuptake inhibitors
This research was supported the National Institute of Mental Health Grants U01MH64089, U01MH64107, U01MH64003, U01MH63747, U01MH064092, and U01MH64088 awarded to the PIs of the Child/Adolescent Anxiety Multimodal Study.
Compliance with Ethical Standards
Conflict of interest
None of the authors have potential conflicts of interest to report.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: Author.Google Scholar
- Derogatis, L. R. (1993). Brief Symptom Inventory: Administration, scoring, and procedures manual. Minneapolis, MN: National Computer Systems.Google Scholar
- Guy, W. (1976). The Clinical Global Impressions. In W. Guy (Ed.), ECDEU assessment manual for psychopharmacology—Revised (pp. 218–222). Rockville, MD: NIMH.Google Scholar
- Lee, P., Zehgeer, A., Ginsburg, G. S., McCracken, J., Keeton, C., Kendall, P. C., et al. (2017). Child and adolescent adherence with cognitive behavioral therapy for anxiety: Predictors and associations with outcomes. Journal of Clinical Child and Adolescent Psychology. https://doi.org/10.1080/15374416.2017.1310046.
- Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., et al. (2009). Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 501–510.CrossRefPubMedGoogle Scholar
- Sabate, E. (2001). Adherence to long-term therapies: Policy for action. Geneva: World Health Organization.Google Scholar
- Silverman, W., & Albano, A. M. (1996). The anxiety disorders interview schedule for DSM-IV: Child and parent versions. San Antonio, TX: The Psychological Corporation.Google Scholar
- Skinner, H., Steinhauer, P., & Santa-Barbara, J. (1995). Family Assessment Measure III (FAM-III). North Tonawanda, NY: Multi-Health Systems.Google Scholar
- Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D., Greenhill, L., Klein, R., et al. (2003). Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 13–21.CrossRefPubMedGoogle Scholar
- Woldu, H., Porta, G., Goldstein, T., Sakolsky, D., Perel, J., Emslie, G., et al. (2011). Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 490–498.CrossRefPubMedPubMedCentralGoogle Scholar